We use a few cookies

Essential cookies keep the library working. With your permission, we'd also like to use analytics to see what's useful and improve the experience. Read our Privacy Policy or Cookie Policy.

Skip to main content
Home/e-Resources/Medical Sciences/Hypercalcemia in granulomatous disorders: a clinical review
PeriodicalsMedical Sciences

Hypercalcemia in granulomatous disorders: a clinical review

Checking your access to this record.

Abstract & Overview

Hypercalcemia occurs in most granulomatous disorders. High serum calcium levels are seen in about 10% of patients with sarcoidosis; hypercalciuria is about three times more frequent. Tuberculosis, fungal granulomas, berylliosis, and lymphomas are other conditions that are associated with disorders of calcium metabolism. These abnormalities of calcium metabolism are due to dysregulated production of 1,25-(OH2)D3 (calcitriol) by activated macrophages trapped in pulmonary alveoli and granulomatous inflammation. Undetected hypercalcemia and hypercalciuria can cause nephrocalcinosis, renal stones, and renal failure. Corticosteroids cause prompt reversal of the metabolic defect. Chloroquine, hydroxychloroquine, and ketoconazole are the drugs that should be used if the patient fails to respond or develops dangerous side effects to corticosteroid therapy.

Cite this record

Om P. Sharma (2000). Hypercalcemia in granulomatous disorders: a clinical review. Current Opinion in Pulmonary Medicine, 6(5), 442–447. https://doi.org/10.1097/00063198-200009000-00010

Copy in another style

Sharma, O. P. (2000). Hypercalcemia in granulomatous disorders: a clinical review. Current Opinion in Pulmonary Medicine, 6(5), 442–447. https://doi.org/10.1097/00063198-200009000-00010
Author names are used as deposited, so check their order before you submit.

Metadata is harvested from open-access indexes and can be incomplete. Check a citation against the published version before relying on it — see our open access & attribution policy.